GA
MR

Geneva Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Geneva Advisors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,140
Closed -$426K – 760
2014
Q3 		$426K Buy
14,140
+1,595
+13% +$49.4K 0.01% 447
2014
Q2 		$395K Buy
+12,545
New +$398K 0.01% 470
2013
Q3 		– Sell
-17,196
Closed -$644K – 564
2013
Q2 		$644K Buy
+17,196
New +$679K 0.02% 265

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Geneva Advisors's MR Position: Q4 2014 in Review

Geneva Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2014, closing a stake of 14,140 shares — an estimated $426K sold.

Geneva Advisors first reported a position in MR in Q2 2013 and held it in 3 quarters. The position peaked at $644K in Q2 2013. 137 funds tracked by Wall St. Rank hold MR as of Q4 2014.

  • Geneva Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2014 after selling out during the quarter.
  • Geneva Advisors sold 14,140 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2014, an estimated $426K.
  • Geneva Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 3 quarters.
  • Geneva Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $644K in Q2 2013.
  • 137 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2014.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.